Revision Skincare® announced a partnership with RVL Pharmaceuticals plc. This strategic partnership pairs two unique disruptors within the aesthetics and skincare industries, both focused on providing patients with high-quality results. With shared values and visions for business growth and an expanding footprint, the collaboration aligns two game-changing brands to offer more accessible solutions to aesthetic patients and providers nationwide.

For more than two decades, Revision Skincare® has been at the forefront of physician-dispensed brands. From pioneering the use of peptides to developing proprietary technologies and conducting novel ingredient research, this professional skincare brand creates clinically validated, high-potency products that protect, treat, and enhance the skin. As another company invested in optimal patient health, RVL Pharmaceuticals offers appropriate patients a nonsurgical solution for acquired ptosis and provides results in as fast as 5 minutes with UPNEEQ.